Unusual case of severe arrhythmia developed after acute intoxication with tosylchloramide

BMC Clinical Pharmacology

Gian Piero Perna¹  Salvatore Amoroso²  Ilaria Battistoni¹  Annamaria Assunta Nasti²  Marco Marini¹  Alessandra Moraca¹  Vincenzo Lariccia² 

[1] Department of Cardiology, Azienda Ospedaliero-Universitaria “Ospedali Riuniti di Ancona”, Ancona, Italy;Department of “Biomedical Sciences and Public Health, University “Politecnica delle Marche”, Ancona, Italy

关键词: Ion channels;    Ventricular fibrillation;    Arrhythmia;    Acute intoxication;    Tosylchloramide;   

Others  :  860661
DOI  :  10.1186/2050-6511-14-8

 received in 2012-09-04, accepted in 2013-01-21,  发布年份 2013

【 摘 要 】

Background

Drugs not commonly considered to be cardioactive agents may cause prolongation of the QT interval with resultant torsades de pointes and ventricular fibrillation. This form of drug toxicity often causes cardiac arrest or sudden death.

Case presentation

After accidental ingestion of tosylchloramide a caucasian 77-year-old woman, with a family history of cardiovascular disease and hypertension, was admitted to the intensive care unit following episodes of torsades de pointes with a prolonged QT/QTc interval (640/542 ms). The patient received an implantable cardioverter-defibrillator, was discharged from the hospital with normal QT/QTc interval and did not experience additional ventricular arrhythmias during one year of follow-up.

Conclusion

This is the first report concerning an unusual case of torsades de pointes after accidental intoxication by ingestion of tosylchloramide. The pronounced impact of the oxidyzing agent tosylchloramide on the activity of some of the ion channels regulating the QT interval was identified as a probable cause of the arrhythmia.

【 授权许可】

   
2013 Lariccia et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Blasco A, Joral A, Fuente R, Rodríguez M, García A, Domínguez A: Bronchial asthma due to sensitization to chloramine T. J Investig Allergol Clin Immunol 1992, 2:167-170.
• [2]Kujala VM, Reijula KE, Ruotsalainen EM, Heikkinen K: Occupational asthma due to chloramine-T solution. Respir Med 1995, 89:693-695.
• [3]Grant WM: Toxicology of the eye. Charles C. Thomas, Srpingfield; 1974.
• [4]Pascuzzi TA, Storrow AB: Mass casualties from acute inhalation of chloramine gas. Mil Med 1998, 163:102-104.
• [5]Gonzalez-Castro A, Holanda MS, Canas BS, Morlote JG, Minambres E, Prieto Solis JA: Myocardial damage after inhalation of chloramines. Eur J Emerg Med 2006, 13:108-110.
• [6]Thygesen K, Alpert JS, White HD: Universal definition of myocardial infarction. Eur Heart J 2007, 28:2525-2538.
• [7]Mihajlovic V, Cascone O, Biscoglio de Jiménez Bonino MJ: Oxidation of methionine residues in equine growth hormone by Chloramine-T. Int J Biochem 1993, 25:1189-1193.
• [8]Kassmann M, Hansel A, Leipold E, Birkenbeil J, Lu SQ, Hoshi T, Heinemann SH: Oxidation of multiple methionine residues impairs rapid sodium channel inactivation. Pflugers Arch 2008, 456:1085-1095.
• [9]Wang GK: Irreversible modification of sodium channel inactivation in toad myelinated nerve fibres by the oxidant chloramine-T. J Physiol 1984, 346:127-141.
• [10]Quiñonez M, DiFranco M, González F: Involvement of methionine residues in the fast inactivation mechanism of the sodium current from toad skeletal muscle fibers. J Membr Biol 1999, 169:83-90.
• [11]Nawada T, Tanaka Y, Hisatome I, Sasaki N, Ohtahara A, Kotake H, Mashiba H, Sato R: Mechanism of inhibition of the sodium current by bepridil in guinea-pig isolated ventricular cells. Br J Pharmacol 1995, 116:1775-1780.
• [12]Niemann P, Schmidtmayer J, Ulbricht W: Chloramine-T effect on sodium conductance of neuroblastoma cells as studied by whole-cell clamp and single-channel analysis. Pflugers Arch 1991, 418:129-136.
• [13]Song Y, Shryock JC, Wagner S, Maier LS, Belardinelli L: Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 2006, 318:214-222.
• [14]Maltsev VA, Sabbah HN, Higgins RS, Silverman N, Lesch M, Undrovinas AI: Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 1998, 98:2545-2552.
• [15]Hasenfuss G, Maier LS: Mechanism of action of the new anti-ischemia drug ranolazine. Clin Res Cardiol 2008, 97:222-226.
• [16]Undrovinas A, Maltsev VA: Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem 2008, 6:348-359.
• [17]Bennett PB, Yazawa K, Makita N, George AL Jr: Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995, 376:683-685.
• [18]Christé G, Chahine M, Chevalier P, Pásek M: Changes in action potentials and intracellular ionic homeostasis in a ventricular cell model related to a persistent sodium current in SCN5A mutations underlying LQT3. Prog Biophys Mol Biol 2008, 96:281-293.
• [19]Tian XL, Yong SL, Wan X, Wu L, Chung MK, Tchou PJ: Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo. Cardiovasc Res 2004, 61:256-267.
• [20]Tseng GN: I(Kr): the hERG channel. J Mol Cell Cardiol 2001, 33:835-849.
• [21]Sanguinetti MC, Jiang C, Curran ME, Keating MT: A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995, 81:299-307.
• [22]Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT: A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80:795-803.
• [23]Chiang CE, Roden DM: The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 2000, 36:1-12.
• [24]Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA: MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999, 97:175-187.
• [25]Su Z, Limberis J, Martin RL, Xu R, Kolbe K, Heinemann SH, Hoshi T, Cox BF, Gintant GA: Functional consequences of methionine oxidation of hERG potassium channels. Biochem Pharmacol 2007, 74:702-711.
• [26]Campbell DL, Stamler JS, Strauss HC: Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 1996, 108:277-293.
• [27]Yamaoka K, Yakehiro M, Yuki T, Fujii H, Seyama I: Effect of sulfhydryl reagents on the regulatory system of the L-type Ca channel in frog ventricular myocytes. Pflugers Arch 2000, 440:207-215.
• [28]Jacobs A, Knight BP, McDonald KT, Burke MC: Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8). Hear Rhythm 2006, 3:967-970.
• [29]Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC, Keating MT: Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31.
• [30]Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT: Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA 2005, 102:8089-8096.
• [31]Barrett CF, Tsien RW: The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc Natl Acad Sci USA 2008, 105:2157-2162.
• [32]Jeong EM, Liu M, Sturdy M, Gao G, Varghese ST, Sovari AA, Dudley SC: Metabolic stress, reactive oxygen species, and arrhythmia. J Mol Cell Cardiol 2012, 52:454-463.
• [33]Liu T, Li G: Antioxidant interventions as novel preventive strategies for postoperative atrial fibrillation. Int J Cardiol 2010, 145:140-142.
• [34]Naccarelli GV, Lukas MA: Carvedilol’s antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction. Clin Cardiol 2005, 28:165-173.